Daily as of 3 Nov 16:00 ET
- Price
- between the two $3.68 vs 50 $3.76 / 200 $3.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Oct 2026 · projected 21 bars out · tested 6 bars
RXRX | Recursion Pharmaceuticals, Inc. Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$3.68
-$0.15 (-3.92%)
Recursion Pharmaceuticals, Inc. Class A (RXRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $4.03 vs 50 $3.66 / 200 $6.50
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $3.68 vs 50 $3.98 / 200 $3.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 8 Sep 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 12 Oct 2026 | 🟨Golden moderate | daily | 21 bars out | 6 bar cross test |
| 8 Sep 2026 | 🟨Golden | 4-hour | 29 bars out | — |
| 4 Aug 2026 | 💀Death | 4-hour | 30 bars out | 2 bar cross test |
| 2 Jul 2026 | 🟨Golden | 4-hour | 7 bars out | Not tested |
| 19 Nov 2025 | 💀Death | 4-hour | 24 bars out | Not tested |
About RXRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$70.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall